Clint Stillwell, MD
Surgery · New Orleans, LANPI 1063945921
Payments from drug & device makers
Across 28 payments — averaging $152.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Intuitive Surgical$1K
- Johnson & Johnson$240
- Integra Lifesciences Corporation$149
- Apollo Endosurgery US Inc$146
- Medtronic$144
- plus $509 from 8 others
What the payments were for
- Travel & lodging$1,92645%
- Food & beverage$1,34031%
- Education$1,00023%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 8 | $2,079 |
| Intuitive Surgical | 1 | $1,000 |
| Johnson & Johnson | 2 | $240 |
| Integra Lifesciences Corporation | 1 | $149 |
| Apollo Endosurgery US Inc | 1 | $146 |
| Medtronic | 2 | $144 |
| Heron Therapeutics, Inc. | 1 | $122 |
| Boston Scientific | 1 | $94 |
| Vertex | 4 | $91 |
| Lexington Medical, Inc. | 2 | $77 |
| TELA Bio, Inc. | 1 | $57 |
| Phathom Pharmaceuticals, Inc. | 2 | $33 |
| Conmed Corporation | 1 | $19 |
| Asensus Surgical, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MONTEREY AL$1,926
- DAVINCI XI$1,000
- INTEGRA$446
- Echelon Flex$240
- OMNIGRAFT$149
- INTEGRA DERMAL REGENERATION TEMPLATE$149
- OverStitch Endoscopic Suturing System$146
- Zynrelef$122
- Signet$105
- Harmonic$101
- Enseal$101
How this compares
$4,266 in reported general payments places this provider in the 65th percentile of 381 surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enoxaparin Sodium | 39 | $2,796 |
| Ondansetron OdtOndansetron | 108 | $1,274 |
| Sucralfate | 21 | $1,042 |
| Omeprazole | 59 | $788 |
| Naloxone Hcl | 11 | $700 |
| Pantoprazole Sodium | 35 | $567 |
| Scopolamine | 31 | $388 |
| Oxycodone Hcl | 93 | $297 |
Paid to pharmacies, not to this prescriber.
Other surgery in New Orleans
- Ari CohenNew Orleans$406K
- Carlos GalvaniNew Orleans$352K
- Douglas SlakeyNew Orleans$318K
- Joseph BuellNew Orleans$212K
- Michael CookNew Orleans$110K
- Ian HodgdonNew Orleans$38K
- Shauna LevyNew Orleans$33K
- Adwoa Opoku-BoatengNew Orleans$30K
- Mohamed-Aly BakeerNew Orleans$27K
- William KethmanNew Orleans$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.